Drug Profile
SPIKET-P
Alternative Names: SPIKET P; Spongistatin 1 analogue; Synthetic spiroketal pyranLatest Information Update: 24 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Pyrans; Spiro compounds
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 02 Aug 2000 Preclinical development for Cancer in USA (Unknown route)